immunotherapy

Checkpoint Therapeutics Appoints Amit Sharma, MD, to Board

Charlotte RobinsonNephrology Times | March 26, 2024

Checkpoint Therapeutics has added Amit Sharma, MD, to its board.

Consolidative Thoracic Radiation Therapy (cTRT) Plus Chemotherapy in Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Patrick DalySmall Cell Lung Cancer | September 21, 2023

Patients with extensive-stage small cell lung cancer (ES-SCLC) continue to face poor survival outcomes. Consolidative ...

Evaluating Adoptive Immunotherapy to Prevent Acute GVHD

DocWire News EditorsASH Annual Meeting and Exposition 2021 | April 6, 2023

Adoptive immunotherapy with CD4+/CD25/+FOXP3+ regulatory T cells (Tregs) and conventional T cells (Tcons) has been used ...

Using Vaccination to Treat Multiple Myeloma, with Dr. Nikhil Munshi

Rebecca AraujoOncology | April 28, 2023

Is a vaccine for multiple myeloma feasible? DocWire News spoke with Nikhil Munshi, MD, Professor at Harvard Medical ...

Treatment Protocols Vary by Disease Stage in Sinonasal DLBCL

Kaitlyn D’OnofrioOncology | May 7, 2021

A study published in The Laryngoscope assessed different treatment modalities for patients with sinonasal diffuse large ...

First Frontline Immunotherapy Approved for Gastric Cancer

Rebecca AraujoGastric Cancer | August 22, 2023

On April 16, the U.S. Food and Drug Administration (FDA) approved nivolumab in combination with fluoropyrimidine- and ...

Hem/Onc Roundup: Financial Burden of Cancer Survivors, Brain Tumors in Kidney Cancer Patients

Rebecca AraujoOncology | April 16, 2021

This week, findings from a clinical trial of children with high-risk Hodgkin lymphoma found the anti-CD30 antibody drug ...

Do Immune Checkpoint Inhibitors Cause Flareups in Autoimmune Diseases?

Kaitlyn D’OnofrioRheumatoid Arthritis | May 2, 2023

A retrospective study found that patients with preexisting autoimmune diseases (PADs) may experience exacerbations ...

Hem/Onc Roundup: Cancer's Long-Term Impact, Lung Cancer Immunotherapy, and more

Rebecca AraujoOncology | November 20, 2020

Lung Cancer Patients with a Specific Human Leukocyte Antigen More Likely to Respond to Immunotherapy ...

Lung Cancer Patients With Specific Human Leukocyte Antigen More Likely to Respond to Immunotherapy

Rob DillardImmunotherapy in NSCLC | November 16, 2020

A new study shows that lung cancer patients with a particular type of human leukocyte antigen (HLA) are more likely to ...

New Approach for CAR-T Cell “Purification” May Reduce Side Effects and Toxicity

Rebecca AraujoOncology | October 20, 2020

Researchers from the biotherapeutics company Carina Biotech and the University of South Australia have developed a ...

Levels of Tumor DNA in Bloodstream Associated with Clinical Outcomes in First-Line Immunotherapy for Melanoma

Rebecca AraujoSkin Cancer | November 7, 2024

A study published in Clinical Cancer Research found that baseline levels of circulating tumor DNA (ctDNA) successfully ...

A New Approach to Immuno-Oncology: Introduction to BiTE<sup>®</sup> Technology

DocWire News EditorsOncology | April 28, 2023

Hem/Onc Round-up: Aspirin in Late-stage Cancer, Smoking and Cancer Screening, and more

Kaitlyn D’OnofrioOncology | September 22, 2023

Here are the top stories recently covered by DocWire News in the hematology/oncology section. In this edition, read ...

Study Shows Pancreatic Cancer Patients Benefit from Immunotherapy

Rob DillardPancreatic Cancer | August 22, 2023

Results from “COMBAT Trial” show pancreatic cancer patients can greatly benefit from immunotherapy. The results were ...

Hem/Onc Round-up: Immunotherapy Safe in COVID-19, HPV Vaccine Rates, and more

Kaitlyn D’OnofrioOncology | July 24, 2020

Here are the top stories recently covered by DocWire News in the hematology/oncology section. In this edition, read ...

Immunotherapy Appears Safe for Cancer Patients with COVID-19

Rob DillardCOVID-19 | April 6, 2023

Immunotherapy doesn't worsen complications for patients with both COVID-19 and cancer, according to a preliminary study ...

Combination of Radiation Therapy and Immunotherapy Shows Promise for Patients with Locally Advanced Head and Neck Cancers

Rob DillardHead and Neck Cancer | April 11, 2023

The findings of a new phase II trial show that the combination of radiation therapy and immunotherapy resulted in ...

A Potential Blood Cancer Vaccine Formula

Rob DillardOncology | December 20, 2019

Researchers have discovered a new way to improve immunotherapy by using genomics to inform immunotherapy treatments for ...

Immunotherapy Tolerable after Chemoradiotherapy in Cervical Cancer Patients

Kaitlyn D’OnofrioCervical Cancer | April 11, 2023

A study published in JAMA Oncology assessed the tolerability of sequential immunotherapy following chemoradiotherapy ...